COGNOSCI, INC.

Company Information

Company Name
COGNOSCI, INC.
Address
79 T. W. Alexander Drive
RESEARCH TRIANGLE PARK, NC, 27709-2076
Phone
n/a
URL
n/a
DUNS
141881727
Number of Employees
n/a
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$5,975,293.00
25
SBIR Phase II
$8,209,142.00
6
STTR Phase I
$714,377.00
3
Chart code to be here

Award List

  1. High Throughput Screen for Novel Anti-Rheumatic Compounds

    Amount: $333,305.00

    DESCRIPTION (provided by applicant): Rheumatoid arthritis (RA) is a chronic, systemic, inflammatory autoimmune disease targeting the synovium, the tissue that lines the joints. It is associated wi ...

    SBIR Phase I 2010 Department of Health and Human Services
  2. IMPROVED ASSAYS FOR SPECIFICALLY MEASURING COLLAGENASE-3

    Amount: $0.00

    DESCRIPTION (provided by applicant): The matrix metalloproteinases (MMPs) are associated with, and may be predictors of diseases such as osteoarthritis (OA), rheumatoid arthritis (RA), and cancer. In ...

    SBIR Phase I 2002 Department of Health and Human Services
  3. IMPROVED ASSAYS FOR SPECIFICALLY MEASURING COLLAGENASE-3

    Amount: $1,412,986.00

    DESCRIPTION (provided by applicant): The matrix metalloproteinases (MMPs) are associated with, and may be predictors of diseases such as osteoarthritis (OA), rheumatoid arthritis (RA), and cancer. In ...

    SBIR Phase II 2002 Department of Health and Human Services
  4. IDENTIFICATION OF NEUROPROTECTIVE APOE-MIMETICS

    Amount: $0.00

    Not Avaialble

    SBIR Phase I 2002 Department of Health and Human Services
  5. IDENTIFICATION OF NEUROPROTECTIVE APOE-MIMETICS

    Amount: $1,456,765.00

    Not Avaialble

    SBIR Phase II 2002 Department of Health and Human Services
  6. NEUROPROTECTIVE APOLIPOPROTEIN-E ANALOGS

    Amount: $201,831.00

    DESCRIPTION (provided by applicant): Apolipoprotein E (apoE) is a 299 amino acid protein that plays a palliative role in the CNS response to acute and chronic injury. We have recently demonstrated tha ...

    SBIR Phase I 2002 Department of Health and Human Services
  7. Neuroprotective Apolipoprotein-E Analogs Continuation

    Amount: $2,609,101.00

    DESCRIPTION (provided by applicant): In our previous grants, we have developed COG1410, a novel anti-inflammatory peptide with additional neuroprotective properties, for the treatment of Traumatic Bra ...

    SBIR Phase II 2008 Department of Health and Human Services
  8. NOVEL INHIBITORS OF BRAIN ISCHEMIA

    Amount: $284,008.00

    DESCRIPTION (provided by applicant): Stroke is a leading cause of death and disability in the United States affecting approximately 750,000 individuals each year. Stroke is characterized by a partial ...

    SBIR Phase I 2003 Department of Health and Human Services
  9. INHIBITION OF CPB-MEDIATED NEUROLOGICAL DYSFUNCTION

    Amount: $214,573.00

    DESCRIPTION (provided by applicant): Cerebral injury remains one of the most frequent and devastating complications of heart surgery, for which there is no known therapy. These injuries, ranging from ...

    SBIR Phase I 2004 Department of Health and Human Services
  10. ENHANCING PEPTIDE DELIVERY TO THE BRAIN

    Amount: $265,517.00

    DESCRIPTION (provided by applicant): There are currently 5.3 million Americans living with a disability as a result of a TBI, at a cost of $48.3 billion annually. The economic and social burden on the ...

    SBIR Phase I 2004 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government